ArticleFrontiers in psychiatry2026
Comparison of inflammatory and ECG markers between children/adolescents with ADHD and healthy controls.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Attention-deficit/hyperactivity disorder (ADHD) has been associated with low-grade systemic inflammation and autonomic dysregulation, but it remains unclear whether these alterations are accompanied by subclinical ventricular electrical heterogeneity in medicated pediatric patients. This study investigated inflammatory markers and the frontal QRS-T angle (fQRS-T) in children and adolescents with ADHD receiving methylphenidate and examined the association between inflammatory burden and fQRS-T. Methods: This single-center retrospective cross-sectional study included 75 children and adolescents with DSM-5 ADHD who had received continuous methylphenidate treatment for at least 6 months and 75 age- and gender-matched healthy controls. Participants with chronic inflammatory, autoimmune, cardiovascular, systemic, or psychiatric comorbidities were excluded. Complete blood count-derived inflammatory indices, including the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV), were calculated. Standard 12-lead electrocardiograms were used to assess heart rate, QT, QTc, QRS duration, and fQRS-T. Results: The ADHD and control groups were similar in age and gender distribution. Conventional ECG parameters, including heart rate, QT, QTc, and QRS duration, did not differ significantly between groups. In contrast, the fQRS-T angle was significantly wider in the ADHD group than in controls (31.05° ± 32.03° vs. 18.62° ± 20.02°; Conclusion: Children and adolescents with ADHD receiving methylphenidate showed a higher inflammatory burden and a wider fQRS-T angle than healthy controls. The association of fQRS-T with SII suggests a possible link between low-grade systemic inflammation and subclinical ventricular electrical heterogeneity in this population. However, because of the retrospective cross-sectional design and the inclusion of only methylphenidate-treated patients, these findings should be interpreted cautiously and considered hypothesis-generating.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.